Interstitial Lung Disease Induced by Pazopanib Treatment

Although pneumothorax has been reported to be a major pulmonary adverse event in patients treated with pazopanib, a multikinase inhibitor, drug-induced interstitial lung disease (DILD) has not been reported. A 74-year-old Japanese man who received pazopanib for the treatment of femoral leiomyosarcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Ide, Shotaro, Sakamoto, Noriho, Hara, Shintaro, Hara, Atsuko, Kakugawa, Tomoyuki, Nakamura, Yoichi, Futsuki, Yoji, Izumikawa, Koichi, Ishimatsu, Yuji, Yanagihara, Katsunori, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313429/
https://www.ncbi.nlm.nih.gov/pubmed/28050004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313429/
https://www.ncbi.nlm.nih.gov/pubmed/28050004

Ejemplares similares